How Weight Loss Medications Actually Work in Your Body
About this episode
This episode explains how GLP-1 receptor agonists work in the body to regulate appetite and metabolism.
Send us Fan Mail We break down the mechanism of action for GLP-1 receptor agonists like tirzepatide (Zepbound/Mounjaro) and semaglutide, explaining how these medications work in the body to regulate appetite and metabolism. • GLP-1 medications contain a C20 fatty diacid that binds to albumin, prolonging half-life • These drugs target both GIP and GLP-1 receptors to regulate appetite and caloric intake • Receptors are found in brain areas involved in appetite regulation and throughout the GI ...
People in this episode
Host: Dr. Damaris Grossmann
Topics covered
- weight loss
- medications
- appetite regulation
- metabolism
- health education
Keywords
- weight loss medications
- GLP-1 receptor agonists
- tirzepatide
- semaglutide
- appetite regulation
- metabolism
Mentioned in this episode
Organizations: Zepbound, Mounjaro, GLP-1, GIP
Products: tirzepatide, semaglutide
More episodes of Mindfully Integrative Show
- Your Body Is Speaking—Are You Listening to These Key Health Indicators?
- Intermittent Fasting Methods: Finding Your Sustainable Timeline
- Metabolic Health Without Extreme Dieting
- When Your Brain Won't Stop Thinking About Food: Strategies for Metabolic Health
- Smart Rings, Real Data, Better Sex
- Nootropics 101: Boosting Your Brain Health Naturally
Explore listener stats, chart rankings, contacts and more on the Mindfully Integrative Show podcast page.